Header Logo

Connection

PETER HOTEZ to Vaccination

Back to Details
This is a "connection" page, showing publications PETER HOTEZ has written about Vaccination.
PETER HOTEZ
Connection Strength
7.830
Vaccination
  1. COVID-19 and the rise of anti-science. Expert Rev Vaccines. 2021 03; 20(3):227-229.
    View in: PubMed
    Score: 0.504
  2. Anti-science kills: From Soviet embrace of pseudoscience to accelerated attacks on US biomedicine. PLoS Biol. 2021 01; 19(1):e3001068.
    View in: PubMed
    Score: 0.502
  3. Anti-science extremism in America: escalating and globalizing. Microbes Infect. 2020 Nov - Dec; 22(10):505-507.
    View in: PubMed
    Score: 0.490
  4. Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles. Curr Opin Virol. 2020 04; 41:1-7.
    View in: PubMed
    Score: 0.471
  5. Vaccines Hesitancy and the Dermatologist. Skinmed. 2018; 16(4):219-221.
    View in: PubMed
    Score: 0.420
  6. "Melanie's measles" is deadly and causes permanent neurologic impairment. Microbes Infect. 2018 02; 20(2):63-64.
    View in: PubMed
    Score: 0.402
  7. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. 2017 09 01; 171(9):887-892.
    View in: PubMed
    Score: 0.396
  8. Texas and Its Measles Epidemics. PLoS Med. 2016 Oct; 13(10):e1002153.
    View in: PubMed
    Score: 0.374
  9. "Vaccine diplomacy": historical perspectives and future directions. PLoS Negl Trop Dis. 2014 Jun; 8(6):e2808.
    View in: PubMed
    Score: 0.318
  10. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS Med. 2005 Oct; 2(10):e295.
    View in: PubMed
    Score: 0.174
  11. What Is the Economic Benefit of Annual COVID-19 Vaccination From the Adult Individual Perspective? J Infect Dis. 2024 Aug 16; 230(2):382-393.
    View in: PubMed
    Score: 0.160
  12. Vaccination and the defence of democracy - Authors' reply. Lancet. 2024 02 10; 403(10426):529-530.
    View in: PubMed
    Score: 0.155
  13. Global Vaccine Access Demands Combating Both Inequity And Hesitancy. Health Aff (Millwood). 2023 12; 42(12):1681-1688.
    View in: PubMed
    Score: 0.153
  14. Vaccine Preventable Disease and Vaccine Hesitancy. Med Clin North Am. 2023 Nov; 107(6):979-987.
    View in: PubMed
    Score: 0.149
  15. On Antiscience and Antisemitism. Perspect Biol Med. 2023; 66(3):420-436.
    View in: PubMed
    Score: 0.143
  16. Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. J Parasitol. 2002 Aug; 88(4):684-90.
    View in: PubMed
    Score: 0.139
  17. Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice. Front Immunol. 2022; 13:800295.
    View in: PubMed
    Score: 0.135
  18. Vaccine Exemptions and the Risk of Continued Disease Outbreaks. Pediatrics. 2022 01 01; 149(1).
    View in: PubMed
    Score: 0.134
  19. Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination. J Infect Dis. 2021 09 17; 224(6):938-948.
    View in: PubMed
    Score: 0.131
  20. Uncoupling vaccination from politics: a call to action. Lancet. 2021 10 02; 398(10307):1211-1212.
    View in: PubMed
    Score: 0.131
  21. Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med. 2021 03; 272:113638.
    View in: PubMed
    Score: 0.125
  22. Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention. Am J Prev Med. 2020 10; 59(4):493-503.
    View in: PubMed
    Score: 0.121
  23. The Potential Economic Value of a Zika Vaccine for a Woman of Childbearing Age. Am J Prev Med. 2020 03; 58(3):370-377.
    View in: PubMed
    Score: 0.117
  24. The 2016 California policy to eliminate nonmedical vaccine exemptions and changes in vaccine coverage: An empirical policy analysis. PLoS Med. 2019 12; 16(12):e1002994.
    View in: PubMed
    Score: 0.116
  25. Length of protection by murine vaccination with living infective third-stage hookworm larvae. Chin Med J (Engl). 1999 Dec; 112(12):1129-32.
    View in: PubMed
    Score: 0.116
  26. Cutaneous and subcutaneous mast cell and eosinophil responses after challenge in mice vaccinated with living infective third-stage hookworm larvae. Chin Med J (Engl). 1999 Nov; 112(11):1020-3.
    View in: PubMed
    Score: 0.115
  27. What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks? J Infect Dis. 2019 08 09; 220(6):920-931.
    View in: PubMed
    Score: 0.113
  28. The Salzburg Statement on Vaccination Acceptance. J Health Commun. 2019; 24(5):581-583.
    View in: PubMed
    Score: 0.113
  29. Trichuris muris whey acidic protein induces type 2 protective immunity against whipworm. PLoS Pathog. 2018 08; 14(8):e1007273.
    View in: PubMed
    Score: 0.106
  30. Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm (Ancylostoma caninum) larvae. J Infect Dis. 1996 Dec; 174(6):1380-3.
    View in: PubMed
    Score: 0.094
  31. Fusion of Na-ASP-2 with human immunoglobulin Fc? abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE. Parasite Immunol. 2012 Aug-Sep; 34(8-9):404-11.
    View in: PubMed
    Score: 0.070
  32. The antipoverty vaccines. Vaccine. 2006 Jul 26; 24(31-32):5787-99.
    View in: PubMed
    Score: 0.045
  33. Vaccines against blood-feeding nematodes of humans and livestock. Parasitology. 2006; 133 Suppl:S63-79.
    View in: PubMed
    Score: 0.044
  34. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine. 2005 Sep 15; 23(39):4754-64.
    View in: PubMed
    Score: 0.043
  35. Pediatric COVID-19 vaccine hesitancy among pregnant and post-partum women: A mixed-method study. Vaccine. 2024 Dec 02; 42(26):126420.
    View in: PubMed
    Score: 0.041
  36. Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms. J Infect Dis. 2004 May 15; 189(10):1952-61.
    View in: PubMed
    Score: 0.039
  37. Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae. J Parasitol. 2003 Aug; 89(4):853-5.
    View in: PubMed
    Score: 0.037
  38. Vaccine access, equity and justice: COVID-19 vaccines and vaccination. BMJ Glob Health. 2023 06; 8(6).
    View in: PubMed
    Score: 0.037
  39. Progress in vaccine development for infectious diseases-a Keystone Symposia report. Ann N Y Acad Sci. 2023 06; 1524(1):65-86.
    View in: PubMed
    Score: 0.036
  40. The legacy of the COVID-19 pandemic for childhood vaccination in the USA. Lancet. 2023 01 07; 401(10370):75-78.
    View in: PubMed
    Score: 0.035
  41. Creation of a Global Vaccine Risk Index. PLoS One. 2022; 17(8):e0272784.
    View in: PubMed
    Score: 0.035
  42. Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA. Lancet. 2022 08 13; 400(10351):535-538.
    View in: PubMed
    Score: 0.035
  43. Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon. PLoS Negl Trop Dis. 2021 10; 15(10):e0009732.
    View in: PubMed
    Score: 0.033
  44. Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout. J Glob Health. 2021 Jun 26; 11:03083.
    View in: PubMed
    Score: 0.032
  45. Childhood immunization during the COVID-19 pandemic in Texas. Vaccine. 2021 06 08; 39(25):3333-3337.
    View in: PubMed
    Score: 0.032
  46. The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine. Am J Prev Med. 2021 05; 60(5):605-613.
    View in: PubMed
    Score: 0.031
  47. Vaccination with chimeric protein induces protection in murine model against ascariasis. Vaccine. 2021 01 08; 39(2):394-401.
    View in: PubMed
    Score: 0.031
  48. Prospects for a safe COVID-19 vaccine. Sci Transl Med. 2020 11 04; 12(568).
    View in: PubMed
    Score: 0.031
  49. The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission. Vaccine. 2020 04 03; 38(16):3261-3270.
    View in: PubMed
    Score: 0.030
  50. Hookworm burden reductions in BALB/c mice vaccinated with recombinant Ancylostoma secreted proteins (ASPs) from Ancylostoma duodenale, Ancylostoma caninum and Necator americanus. Vaccine. 2000 Jan 06; 18(11-12):1096-102.
    View in: PubMed
    Score: 0.029
  51. Antibody-dependent reductions in mouse hookworm burden after vaccination with Ancylostoma caninum secreted protein 1. J Infect Dis. 1999 Nov; 180(5):1674-81.
    View in: PubMed
    Score: 0.029
  52. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans. PLoS Negl Trop Dis. 2019 09; 13(9):e0007730.
    View in: PubMed
    Score: 0.029
  53. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2019 05; 13(5):e0007413.
    View in: PubMed
    Score: 0.028
  54. Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients. Vaccine. 2019 06 19; 37(28):3704-3714.
    View in: PubMed
    Score: 0.028
  55. Resurgence of Vaccine-Preventable Diseases in Venezuela as a Regional Public Health Threat in the Americas. Emerg Infect Dis. 2019 04; 25(4):625-632.
    View in: PubMed
    Score: 0.028
  56. IgG Induced by Vaccination With Ascaris suum Extracts Is Protective Against Infection. Front Immunol. 2018; 9:2535.
    View in: PubMed
    Score: 0.027
  57. Covalent vaccination with Trypanosoma cruzi Tc24 induces catalytic antibody production. Parasite Immunol. 2018 Nov; 40(11):e12585.
    View in: PubMed
    Score: 0.027
  58. Electron and light microscopy of peritoneal cellular immune responses in mice vaccinated and challenged with third-stage infective hookworm (Ancylostoma caninum) larvae. Acta Trop. 1998 Sep 15; 71(2):155-67.
    View in: PubMed
    Score: 0.027
  59. Cutaneous and subcutaneous granulomata formation in mice immunized and challenged with third-stage infective hookworm (Ancylostoma caninum) larvae. Acta Trop. 1998 Jun; 69(3):229-38.
    View in: PubMed
    Score: 0.026
  60. Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease. Infect Immun. 2018 04; 86(4).
    View in: PubMed
    Score: 0.026
  61. Vaccines for hookworm infection. Pediatr Infect Dis J. 1997 Oct; 16(10):935-40.
    View in: PubMed
    Score: 0.025
  62. Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune response. PLoS Negl Trop Dis. 2017 Jul; 11(7):e0005769.
    View in: PubMed
    Score: 0.025
  63. The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice. PLoS Negl Trop Dis. 2016 07; 10(7):e0004797.
    View in: PubMed
    Score: 0.023
  64. Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Rev Vaccines. 2012 Sep; 11(9):1043-55.
    View in: PubMed
    Score: 0.018
  65. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol. 2012 Jul; 130(1):169-76.e6.
    View in: PubMed
    Score: 0.017
  66. Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths. Vaccine. 2011 May 09; 29(20):3686-94.
    View in: PubMed
    Score: 0.016
  67. Rabies, still neglected after 125 years of vaccination. PLoS Negl Trop Dis. 2010 Nov 30; 4(11):e839.
    View in: PubMed
    Score: 0.016
  68. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection. FASEB J. 2009 Sep; 23(9):3007-19.
    View in: PubMed
    Score: 0.014
  69. Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. Clin Vaccine Immunol. 2007 Mar; 14(3):281-7.
    View in: PubMed
    Score: 0.012
  70. The impact of concurrent and treated Ancylostoma ceylanicum hookworm infections on the immunogenicity of a recombinant hookworm vaccine in hamsters. J Infect Dis. 2006 Jan 01; 193(1):155-62.
    View in: PubMed
    Score: 0.011
  71. Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs. Vaccine. 2006 Jan 23; 24(4):501-9.
    View in: PubMed
    Score: 0.011
  72. Electron and light microscopy of neutrophil responses in mice vaccinated and challenged with third-stage infective hookworm (Ancylostoma caninum) larvae. Parasitol Int. 2001 Nov; 50(4):241-8.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.